The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Open accessAbstract
We have demonstrated previously that the oncoprotein Mdm2 has a ubiquitin ligase activity for the tumor suppressor p53 protein. In the present study, we characterize this ubiquitin ligase activity of Mdm2. We first demonstrate the ubiquitination of several p53 point mutants and deletion mutants by Mdm2. The point mutants, which cannot bind to Mdm2, are not ubiquitinated by Mdm2. The ubiquitination of the C-terminal deletion mutants, which contain so-called Mdm2-binding sites, is markedly decreased, compared with that of wild-type p53. The binding of Mdm2 to p53 is essential for ubiquitination, but p53's tertiary structure and/or C-terminal region may also be important for this reaction. DNA-dependent protein kinase is known to phosphorylate p53 on Mdm2-binding sites, where DNA damage induces phosphorylation, and p53 phosphorylated by this kinase is not a good substrate for Mdm2. This suggests that DNA damage-induced phosphorylation stabilizes p53 by inhibiting its ubiquitination by Mdm2. We further investigated whether the tumor suppressor p19(ARF) affects the ubiquitin ligase activity of Mdm2 for p53. The activity of p19(ARF)-bound Mdm2 was found to be lower than that of free Mdm2, suggesting that p19(ARF) promotes the stabilization of p53 by inactivating Mdm2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the tumor suppressor genes that stabilize p53 (Trp53) via inactivation of Mdm2 in response to a variety of oncogenic stresses (Honda and Yasuda, 1999;Brummelkamp et al., 2002;Lingbeek et al., 2002;Kim and Sharpless, 2006).”
From Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression (2008) · cites this paper as Honda and Yasuda, 1999
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tbx3 is known as a transcriptional repressor for p19 ARF (Cdkn2a -Mouse Genome Informatics) and p14 ARF (the human ortholog of p19 ARF )”
From Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression (2008) · cites this paper as Honda and Yasuda, 1999
Experimental — accuracy not yet measuredIn the citing paper
“These data suggested that transfected GFP-Mdm2 is a labile protein that is a target for degradation (20,21) and, furthermore, that PKB phosphorylation is required for protecting Mdm2 from proteasome-dependent destruction, thus increasing Mdm2 stability.”
From Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation (2004) · cites this paper as [20]
In the citing paper
“Mdm2 harbors a self-and p53specific E3 ubiquitin ligase activity within its evolutionarily conserved C-terminal RING finger domain, which mediates p53 ubiquitination and rapid degradation by the 26 S proteasome (20,21).”
From Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation (2004) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“When Mdm2 cDNA is transfected into human cells, p53 degradation is accelerated (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cited by
Sorted by citations
Items 401–500 of 721
Kashuba, E., Mattsson, K., Tamm, K. P., Kiss, C., Protopopova, M., Ehlin‐Henriksson, B., Klein, G., & Székely, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11124 · Cited by 35
Kim, H. H., Jeong, W., Ahn, K., Ahn, C., & Kang, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133490.00348.59 · Cited by 35
Regulation of the p53 pathway by Ras, the plot thickens
McMahon, M., & Woods, D. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00027-5 · Cited by 35
The contribution of the RING finger domain of MDM2 to cell cycle progression
Argentini, M., Barboule, N., & Wasylyk, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203737 · Cited by 35
Novel Nucleolar Pathway Connecting Intracellular Energy Status with p53 Activation
Kumazawa, T., Nishimura, K., Kuroda, T., Ono, W., Yamaguchi, C., Katagiri, N., Tsuchiya, M., Masumoto, H., Nakajima, Y., Murayama, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209916 · Cited by 34
MDM2 expression in EBV-infected nasopharyngeal carcinoma cells
Wu, H., Lu, T., Lee, J.-J., Hwang, J.-K., Lin, Y., Wang, C.-K., & Lin, C. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700183 · Cited by 34
Dong, Y., Sui, L., Sugimoto, K., Tai, Y., & Tokuda, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4 · Cited by 87
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 33
Oligomerization of the Human ARF Tumor Suppressor and Its Response to Oxidative Stress
Ménendez, S., Khan, Z., Coomber, D., Lane, D. P., Higgins, M., Koufali, M. M., & Laı́n, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211007200 · Cited by 35
Saha, T., Vardhini, D., Tang, Y., Katuri, V., Jogunoori, W. S., Volpe, E., Haines, D., Sidawy, A. N., Zhou, X., Gallicano, G. I., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209123 · Cited by 33
Eischen, C. M., Alt, J. R., & Wang, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208052 · Cited by 32
Hasan, M., Yaguchi, T., Harada, J., Hirano, T., Wadhwa, R., & Kaul, S. C. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.663 · Cited by 33
p53 Activation in Chronic Radiation-Treated Breast Cancer Cells
Xia, L., Paik, A. S., & Li, J. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0969 · Cited by 33
DNA-binding independent cell death from a minimal proapoptotic region of E2F-1
Bell, L. A., O’Prey, J., & Ryan, K. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209580 · Cited by 33
Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF
Dai, M., Challagundla, K. B., Sun, X., Palam, L. R., Zeng, S. X., Wek, R. C., & Lu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311902 · Cited by 31
Woerden, N. L. R.-V., Pieters, R., Slater, R. M., Loonen, A. H., Beverloo, H. B., van Drunen, E., Heyman, M. M., Moreno, T. C., Rots, M. G., Wering, E. R., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02586.x · Cited by 32
Polyoma virus disrupts ARF signaling to p53
Lomax, M. E., & Fried, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204717 · Cited by 32
A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins
Wadhwa, R., Sugihara, T., Hasan, M. K., Taira, K., Reddel, R. R., & Kaul, S. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203222200 · Cited by 31
Hsu, S., & Lee, W. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0424 · Cited by 30
Kang, H., Lim, J. W., & Kim, H. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.08.003 · Cited by 30
Adult neural stem cells and their role in brain pathology
Yadırgı, G., & Marino, S. (2008) · The Journal of Pathology · doi:10.1002/path.2480 · Cited by 30
Modulation of the ARF-p53 Pathway by the Small DNA Tumor Viruses
O’Shea, C. C., & Fried, M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1555 · Cited by 29
mdm2 mRNA Level is a Prognostic Factor in Soft Tissue Sarcoma
Taubert, H. W., Koehler, T., Meye, A., Bartel, F., Lautenschläger, C., Borchert, S., Bache, M., Schmidt, H., & Würl, P. (2000) · Molecular Medicine · doi:10.1007/bf03401934 · Cited by 30
Decreased Mdm2 expression inhibits tumor development induced by loss of ARF
Wang, P., Greiner, T. C., Lushnikova, T., & Eischen, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209411 · Cited by 29
Yang, H., Xiang, S., Kazi, A., & Sebti, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011930 · Cited by 29
Britigan, E. M. C., Wan, J., Zasadil, L. M., Ryan, S. D., & Weaver, B. A. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0966 · Cited by 30
Reactivating the ARF-p53 axis in AML cells by targeting ULF
Chen, D., Yoon, J., & Gu, W. J. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12355 · Cited by 33
p53-independent apoptosis is induced by the p19ARF tumor suppressor
Tsuji, K., Mizumoto, K., Sudo, H., Kouyama, K., Ogata, E., & Matsuoka, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00723-4 · Cited by 29
Pathogenesis of diffuse large B cell lymphoma
Chan, W. C. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0602-0 · Cited by 28
The Roles of E6-AP and MDM2 in p53 Regulation in Human Papillomavirus-Positive Cervical Cancer Cells
Chomnawang, M. T., Chen, L., Yu, D. S., Agrawal, S., & CHEN, J. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.17 · Cited by 28
The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells
Kim, H., You, S., Foster, L. K., Farris, J., & Foster, D. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204664 · Cited by 28
Kashuba, E., Mattsson, K., Klein, G., & Székely, L. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-18 · Cited by 28
Robust p53 Stabilization Is Dispensable for Its Activation and Tumor Suppressor Function
Kon, N., Churchill, M., Li, H., Mukherjee, S., Manfredi, J. J., & Gu, W. J. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1804 · Cited by 27
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26
Spontaneous Uveal Amelanotic Melanoma in Transgenic Tyr-RAS+ Ink4a/Arf−/− Mice
Tolleson, W. H. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.8.1088 · Cited by 27
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Tecleab, A., Zhang, X., & Sebti, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565796 · Cited by 27
Neural stem cells, tumour stem cells and brain tumours: Dangerous relationships?
SUTTER, R., Yadırgı, G., & Marino, S. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.006 · Cited by 28
Alternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors
James, M. C., & Peters, G. G. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_7 · Cited by 27
Diesel exhaust particles induce apoptosis via p53 and Mdm2 in J774A.1 macrophage cell line
Yun, Y.-P., Lee, J., Ahn, E., Lee, K.-H., Yoon, H. K., & Lim, Y. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.09.018 · Cited by 29
The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain
Mellert, H. S., Sykes, S. M., Murphy, M. E., & McMahon, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4343 · Cited by 32
Piboonniyom, S.-O., Timmermann, S., Hinds, P. W., & Münger, K. (2002) · Oral Oncology · doi:10.1016/s1368-8375(01)00042-2 · Cited by 27
Zeng, X., Keller, D., Wu, L., & Lu, H. (2000) · PubMed · Cited by 26
The Tumor Suppressor ARF Regulates Innate Immune Responses in Mice
Través, P. G., López-Fontal, R., Luque, A., & Hortelano, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004070 · Cited by 27
The Nucleolus and Ribosomal Genes in Aging and Senescence
Hein, N., Sanij, E., Quin, J. E., Katherine, M., Ganley, A. R. D., & Ross, D. (2012) · InTech eBooks · doi:10.5772/34581 · Cited by 25
ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation
Miao, L., Song, Z., Jin, L., Zhu, Y., Wen, L., & Wu, M. (2009) · Oncogene · doi:10.1038/onc.2009.372 · Cited by 26
Matsuda–Imai, N., Matsumoto, S., & Kang, W. (2005) · Journal of General Virology · doi:10.1099/vir.0.80523-0 · Cited by 26
Iqbal, J., Naushad, H., Bi, C., Yu, J., Bouska, A. C., Rohr, J. M., Chao, W., Fu, K., Chan, W. C., & Vose, J. M. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.08.002 · Cited by 28
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27
David-Pfeuty, T., & Nouvian-Dooghe, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205871 · Cited by 26
Calabrò, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., & Mantia, G. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8529-8540.2004 · Cited by 26
CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci
Cameron, D. P., Sornkom, J., Alsahafi, S., Drygin, D., Poortinga, G., McArthur, G. A., Hein, N., Hannan, R. D., & Panov, K. I. (2024) · Biomedicines · doi:10.3390/biomedicines12071514 · Cited by 28
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
Reed, S. M., Hagen, J., Tompkins, V. S., Thies, K., Quelle, F. W., & Quelle, D. E. (2014) · Cell Cycle · doi:10.4161/cc.28202 · Cited by 25
Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma
Isaacs, J. S., Saito, S., & Neckers, L. Μ. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100638200 · Cited by 25
Zhou, R., Frum, R. A., Deb, S., & Deb, S. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-3755 · Cited by 24
Brady, S. N., Maggi, L. B., Winkeler, C. L., Toso, E. A., Gwinn, A. S., Pelletier, C. L., & Weber, J. D. (2009) · Oncogene · doi:10.1038/onc.2009.178 · Cited by 24
Kaku, S. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.1989 · Cited by 24
RNA polymerase III transcription is repressed in response to the tumour suppressor ARF
Morton, J. P., Kantidakis, T., & White, R. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm208 · Cited by 24
Tango, Y., Fujiwara, T., Itoshima, T., Takata, Y., Katsuda, K., Uno, F., Ohtani, S., Tani, T., Roth, J. A., & Tanaka, N. (2002) · Human Gene Therapy · doi:10.1089/104303402760128595 · Cited by 24
Mdm2 Inhibits the Apoptotic Function of p53 Mainly by Targeting It for Degradation
Yap, D., Hsieh, J.-K., & Lü, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004359200 · Cited by 24
Chemopreventive Agent 3,3′-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells
Gao, X., Liu, J., Cho, K. B., Kedika, S. R., & Guo, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134642 · Cited by 23
Huang, Y., Hasegawa, H., Wang, S.-W., Ku, C., Lin, Y., Chiou, S., Hou, M., Wu, D., Tsai, E., Saito, S., et al. (2010) · BioMed Research International · doi:10.1155/2011/569034 · Cited by 24
Hashikawa, K.-I., Katamune, C., Kusunose, N., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-10599-1 · Cited by 22
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang, H., Luo, J., & Lei, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108910 · Cited by 23
HDM2-Binding Partners: Interaction with Translation Elongation Factor EF1α
Frum, R. A., Busby, S. A., Ramamoorthy, M., Deb, S., Shabanowitz, J., Hunt, D. F., & Deb, S. P. (2007) · Journal of Proteome Research · doi:10.1021/pr060584p · Cited by 23
CARF: An emerging regulator of p53 tumor suppressor and senescence pathway
Cheung, C., Hasan, M. K., Widodo, N., Kaul, S. C., & Wadhwa, R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.05.002 · Cited by 23
Genetic Variation in MDM2 and p14ARF and Susceptibility to Salivary Gland Carcinoma
Jin, L., Xu, L., Song, X., Wei, Q., Sturgis, E. M., & Li, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049361 · Cited by 23
Melchior, F., & Hengst, L. (2000) · Nature Cell Biology · doi:10.1038/35023639 · Cited by 22
Resistance of CD1d−/− Mice to Ultraviolet-Induced Skin Cancer Is Associated with Increased Apoptosis
Matsumura, Y., Moodycliffe, A. M., Nghiem, D. X., Ullrich, S. E., & Ananthaswamy, H. N. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63350-0 · Cited by 21
RNF125 is a Ubiquitin-Protein Ligase that Promotes p53 Degradation
Yang, L., Zhou, B., Li, X., Lu, Z., Li, W., Huo, X., & Miao, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369691 · Cited by 21
P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes
Weige, C. C., Allred, K. F., Armstrong, C. M., & Allred, C. D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.10.010 · Cited by 22
The ARF‐p16 Gene Locus in Carcinogenesis and Therapy of Head and Neck Squamous Cell Carcinoma
Yarbrough, W. G. (2002) · The Laryngoscope · doi:10.1097/00005537-200212000-00002 · Cited by 20
Muhammad, T., Sakhawat, A., Khan, A. A., Huang, H., Khan, H. R., Huang, Y., & Wang, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03157-2 · Cited by 21
Nikolić, N., Aničić, B., Čarkić, J., Simonović, J., Toljić, B., Tanić, N., Tepavčević, Z., Vukadinović, M., Konstantinović, V. S., & Milašin, J. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.08.011 · Cited by 21
Bernard, B., Prétet, J., Charlot, J., & Mougin, C. (2003) · Biology of the Cell · doi:10.1016/s0248-4900(02)01220-0 · Cited by 21
Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF
Packer, L., Pavey, S. J., Boyle, G. M., Stark, M. S., Ayub, A. L. P., Rizos, H., & Hayward, N. K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22725 · Cited by 21
Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells
Parrillas, V., Martínez‐Muñoz, L., Holgado, B., Kumar, A., Cascio, G., Lucas, P., Rodrı́guez-Frade, J. M., Malumbres, M., Carrera, A. C., van Wely, K. H. M., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1145-8 · Cited by 20
Ganzenmueller, T., Matthaei, M., Muench, P., Scheible, M. H., Iftner, A., Hiller, T., Leiprecht, N., Probst, S., Stubenrauch, F., & Iftner, T. (2007) · Virology · doi:10.1016/j.virol.2007.11.006 · Cited by 20
Vestey, S. B., Sen, C., Calder, C. J., Perks, C. M., Pignatelli, M. N., & Winters, Z. (2004) · Breast Cancer Research · doi:10.1186/bcr912 · Cited by 20
Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death
Lee, C. K., Yang, Y., Chen, C., & Liu, J. (2015) · Oncogene · doi:10.1038/onc.2015.275 · Cited by 21
Wood, N. T., Meek, D. W., & MacKintosh, C. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.003 · Cited by 20
The p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20
Reconstructing Signal Transduction Pathways
Levine, A. J., Hu, W., Feng, Z., & Gil, G. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1407.018 · Cited by 20
Saadatmandi, N., Tyler, T., Huang, Y., Haghighi, A. P., Frost, G., Borgström, P., & Gjerset, R. A. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700505 · Cited by 20
Schmid, G., Kramer, M. P., Maurer‐Granofszky, M., Wandl, S., & Węsierska‐Gądek, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21383 · Cited by 20
Nucleolar p14ARF Overexpression in Reed-Sternberg Cells in Hodgkin's Lymphoma
García, J. F., Villuendas, R., Sánchez‐Beato, M., Sánchez‐Aguilera, A., Sánchez, L., Priéto, I., & Piris, M. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64876-6 · Cited by 20
Dey, D. C., Bronson, R. T., Dahl, J., Carroll, J. P., & Benjamin, T. L. (2000) · PubMed · Cited by 20
Update on the Molecular Pathology of Cutaneous Squamous Cell Carcinoma
Cozma, E. C., Banciu, L. M., Soare, C., & Creţoiu, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076646 · Cited by 22
Molecular bridging of aging and cancer
Cheung, C., Kaul, S. C., & Wadhwa, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05392.x · Cited by 20
Novel murine B‐cell lymphoma/leukemia model to study BCL2‐driven oncogenesis
Meijerink, J. P. P., Lieshout, E. M. M. V., Beverloo, H. B., van Drunen, E., Mensink, E. J. B. M., Macville, M. V. E., & Pieters, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20822 · Cited by 19
Rauh‐Adelmann, C., Lau, K., Sabeti, N., Long, J. P., Mok, S. C., & Ho, S. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200008)28:4 · Cited by 48
Valeri, A., Chiricosta, L., Calcaterra, V., Biasin, M., Cappelletti, G., Carelli, S., Zuccotti, G., Bramanti, P., Pelizzo, G., Mazzon, E., et al. (2021) · Cells · doi:10.3390/cells10092189 · Cited by 18
Cellular‐signaling pathways unveil the carcinogenic potential of chemicals
Hendriks, G., van de Water, B., Schoonen, W. G. E. J., & Vrieling, H. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2845 · Cited by 18
Anticancer Agents Based on Vulnerable Components in a Signalling Pathway
Vaidya, A., Jain, S., Sahu, S. K., Jain, P. K., Pathak, K., Pathak, D., Kumar, R., & Jain, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200212105417 · Cited by 18
Do peptides control their own birth and death?
Fåhræus, R. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1590 · Cited by 18
Pierce1, a Novel p53 Target Gene Contributing to the Ultraviolet-Induced DNA Damage Response
Sung, Y. H., Kim, H. J., Devkota, S., Roh, J., Lee, J., Rhee, K., Bahk, Y. Y., & Lee, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0031 · Cited by 19
Histone Chaperone Jun Dimerization Protein 2 (JDP2): Role in Cellular Senescence and Aging
Huang, Y., Saito, S., & Yokoyama, K. K. (2010) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(10)70081-4 · Cited by 20
Nakamura, S., Roth, J. A., & Mukhopadhyay, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205343 · Cited by 18
The ARF-p53 senescence pathway in mouse and human cells.
Wadhwa, R., Sugihara, T., Taira, K., & Kaul, S. C. (2004) · PubMed · doi:10.14670/hh-19.311 · Cited by 17
Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF
Lo, D., Zhang, Y., Dai, M.-S., Sun, X.-X., Zeng, S. X., & Lu, H. (2014) · Oncogene · doi:10.1038/onc.2014.103 · Cited by 22
Ei24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation
Sung, Y. H., Jin, Y., Kang, Y., Devkota, S., Lee, J., Roh, J.-I., & Lee, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477570 · Cited by 17
Metadata
- Authors
- Honda, R., & Yasuda, H.
- Affiliations
- Tokyo University of Pharmacy and Life Sciences (JP)
- Corresponding author
- Yasuda, Hideyo
- Venue
- The EMBO Journal
- Published
- 1999-01-04
- Volume
- 18
- Issue
- 1
- Pages
- 22-27
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1171098
- OpenAlex
- W2028210102
- Cited by
- 724
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 12 · 2022: 12 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 11 · 2017: 5 · 2016: 14 · 2015: 19 · 2014: 20 · 2013: 24 · 2012: 20
- FWCI
- 33.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Molecular Biology Organization
- Institute of Genetics
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p19ARF, MDM2, p53, ubiquitin ligase activity, p53 ubiquitination, p53 stabilization, DNA-dependent protein kinase, p53 phosphorylation, DNA damage response, tumor suppressor proteins, protein-protein interaction
- MeSH terms
- Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, HeLa Cells, Humans, Ligases, Mutation, Nuclear Proteins, Phosphorylation, Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Ubiquitins, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Spodoptera, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
